Off-label use of prescription medications, a common practice that healthcare providers have long relied on and that pharmaceutical companies have profited from, has become the subject of a great deal of controversy. Billions in settlements have been paid out to patients who were allegedly harmed as a result of the off-label... Read more »

On May 7, 2013, Benjamin B. Reade, Sr. suffered large, bilateral pulmonary emboli and cardiac arrest. He did not survive. The previous day, he had discontinued taking AndroGel, a testosterone replacement therapy product that he had been using since March 20, 2013. On May 7, 2015, his widow, Laura Reade,... Read more »

  Another lawsuit has been transferred to the Xarelto multidistrict litigation (MDL) No. 2592, which is pending in the U.S. District Court for the Eastern District of Louisiana under Judge Fallon. The plaintiff, Cheryl Butler, claims the defendants, Janssen Pharmaceuticals, Bayer Healthcare Pharmaceuticals, et al. fraudulently misrepresented the safety of the... Read more »

A Risperdal lawsuit that was pending in a Philadelphia court resulted in a mixed outcome for the plaintiff. The 19-year-old man filed the lawsuit against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, claiming that the defendants’ medication resulted in the abnormal growth of breast tissue. On Friday, March 20, the... Read more »

A mother of two young children has filed a Zofran lawsuit against GlaxoSmithKline (GSK) alleging that the anti-nausea medication led to both of her children’s serious health problems. The Minnesota mother filed her lawsuit on behalf of herself and her minor children in the U.S. District Court for the Eastern... Read more »

A recent study published in the medical journal Clinical Pharmacology & Therapeutics evaluated the possibility that the anti-nausea drug, Zofran (ondansetron) might be used to treat neonatal abstinence syndrome. In doing so, the researchers also assessed the possible transfer of the drug from mother to fetus via the placenta. Zofran... Read more »

To date, about 100 Xarelto lawsuits filed in federal court systems have been centralized into a multidistrict litigation (MDL), which is proceeding in the U.S. District Court for the Eastern District of Louisiana. Judge Eldon E. Fallon is presiding over the MDL, which was established in December 2014 by the... Read more »

A resident of Minnesota has filed a Risperdal lawsuit, alleging that the medication resulted in gynecomastia and other severe complications. The lawsuit, which was filed in the U.S. District Court for the District of Minnesota, names Johnson & Johnson Company and Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, as... Read more »

Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas recently issued an order that has created a mass tort docket for Xarelto lawsuits filed against Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals. The January 21, 2015 order affects at least 75 cases that share common allegations regarding the medication,... Read more »

When patients take a medication, they generally trust that the drug is reasonably safe and will treat their medical condition without the risk of long-term, serious side effects. When drug manufacturers breach that trust, a product liability lawsuit may result. Such is the case with Merck and Co., which found... Read more »